Jiangsu Sihuan Bioengineering: Response from China Audit Asia Pacific Accounting Firm to the inquiry letter on the 2023 annual report of Jiangsu Sihuan Biology Co., Ltd.

SZSI · May 31

The translation is provided by third-party software.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.